Výsledky vyhledávání - "Viral Load/drug effects"

Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort: results from the Dutch ATHENA national observational cohort

Autoři: Jongen, V.W. Wit, F.W. Boyd, A. a další

Zdroj: The Lancet HIV, 12, 1, pp. e40-e50

Témata: Adult, Male, Pyridones/administration & dosage, HIV Infections/drug therapy, Diketopiperazines, Middle Aged, Viral/blood, Viral Load/drug effects, Cohort Studies, Treatment Outcome, HIV-1/drug effects, Anti-HIV Agents/therapeutic use, Rilpivirine/therapeutic use, Humans, RNA, Female, Pharmacy, Pharmacology and Toxicology - Radboud University Medical Center, Netherlands

Přístupová URL adresa: https://hdl.handle.net/2066/315836

Risk of Tuberculosis After Achieving HIV Virological Suppression on Antiretroviral Therapy: A Danish Nationwide Prospective Cohort Study: a Danish nationwide prospective cohort study

Autoři: Amrit Kaur Virdee Fredrikke Christie Knudtzen Josep M Llibre a další

Zdroj: Virdee, A K, Knudtzen, F C, Llibre, J M, Omland, L H, Obel, N, Stærke, N B, Åhsberg, J, Ørsted, I, Kronborg, G, Mohey, R, Montejo, M D P F, Johansen, I S & Martin-Iguacel, R 2024, 'Risk of tuberculosis after achieving HIV virological suppression on antiretroviral therapy: a Danish nationwide prospective cohort study', Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae499
Virdee, A K, Knudtzen, F C, Llibre, J M, Omland, L H, Obel, N, Stærke, N B, Åhsberg, J, Ørsted, I, Kronborg, G, Mohey, R, Montejo, M D P F, Johansen, I S & Martin-Iguacel, R 2025, 'Risk of Tuberculosis After Achieving HIV Virological Suppression on Antiretroviral Therapy : A Danish Nationwide Prospective Cohort Study', Clinical Infectious Diseases, vol. 80, no. 4, pp. 854-863. https://doi.org/10.1093/cid/ciae499

Témata: Male, Adult, Anti-HIV Agents, Denmark, Incidence, HIV Infections/drug therapy, HIV Infections, Middle Aged, Viral Load, antiretroviral therapy (ART), Viral Load/drug effects, Denmark/epidemiology, Risk Factors, Anti-HIV Agents/therapeutic use, Tuberculosis/epidemiology, risk factors, Humans, Tuberculosis, HIV viral suppression, Female, HIV/tuberculosis coinfection, Prospective Studies

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39378332
https://vbn.aau.dk/da/publications/2f05dfb8-e63c-4e4d-9365-ea4cb609c458
https://doi.org/10.1093/cid/ciae499

Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study: a nationwide, matched, prospective cohort study

Autoři: Patrick G A Oomen Ferdinand W N M Wit Kees Brinkman a další

Přispěvatelé: Patrick G A Oomen Ferdinand W N M Wit Kees Brinkman a další

Zdroj: ATHENA National Observational Cohort Study 2024, 'Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV : a nationwide, matched, prospective cohort study', The Lancet HIV, vol. 11, no. 9, pp. e576-e585. https://doi.org/10.1016/S2352-3018(24)00150-4
The Lancet HIV, 11, 9, pp. e576-e585

Témata: Male, Adult, Pyridones, Anti-HIV Agents, Drug Substitution, HIV Infections/drug therapy, HIV Infections, Viral Load, Middle Aged, Triazoles, 16. Peace & justice, Viral Load/drug effects, CD4 Lymphocyte Count, 3. Good health, Treatment Outcome, SDG 3 - Good Health and Well-being, Anti-HIV Agents/therapeutic use, Journal Article, Humans, Female, Prospective Studies, Pyridones/therapeutic use, Triazoles/therapeutic use, Pharmacy, Pharmacology and Toxicology - Radboud University Medical Center

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39209387
https://pure.eur.nl/en/publications/18884f4b-3535-4001-aea6-01c28c71d9de
https://doi.org/10.1016/s2352-3018(24)00150-4
https://research.vumc.nl/en/publications/fe2183aa-896f-446d-ba58-0fd5ae96982d
https://dspace.library.uu.nl/handle/1874/455789
https://pure.amsterdamumc.nl/en/publications/2f620819-7426-4a09-9b54-a7636b960b6e
https://doi.org/10.1016/S2352-3018(24)00150-4
https://hdl.handle.net/2066/310801

Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine

Autoři: Micol Pallanza Paul Thoueille Myriam Briki a další

Zdroj: Antiviral therapy, vol. 30, no. 2, pp. 13596535251335080

Témata: Male, Adult, Sustained Virologic Response, Pyridones, Humans, Oxazines, Piperazines, Heterocyclic Compounds, 3-Ring/administration & dosage, Heterocyclic Compounds, 3-Ring/therapeutic use, HIV Infections/drug therapy, HIV Infections/virology, Carbamazepine/therapeutic use, Carbamazepine/administration & dosage, HIV Integrase Inhibitors/administration & dosage, HIV Integrase Inhibitors/therapeutic use, Drug Interactions, Drug Monitoring, HIV-1/drug effects, Viral Load/drug effects, HIV, carbamazepine, dolutegravir, once daily, plasma levels, strong inducer, HIV Infections, Viral Load, Carbamazepine, HIV-1, HIV Integrase Inhibitors, Heterocyclic Compounds, 3-Ring

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/40230016
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_94CAA7C420227
https://serval.unil.ch/resource/serval:BIB_94CAA7C42022.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_94CAA7C42022

CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus

Autoři: Ferrero, Fernando Lin, Chien-Yu Liese, Johannes a další

Zdroj: Paediatr Drugs

Témata: Male, ddc:610, Dose-Response Relationship, Drug, Infant, Newborn, Infant, Respiratory Syncytial Virus Infections, Viral Load, Antiviral Agents, Dose-Response Relationship, Drug [MeSH], Infant, Newborn [MeSH], Double-Blind Method [MeSH], Female [MeSH], Viral Load/drug effects [MeSH], Antiviral Agents/adverse effects [MeSH], Humans [MeSH], Antiviral Agents/pharmacokinetics [MeSH], Treatment Outcome [MeSH], Infant [MeSH], Male [MeSH], Antiviral Agents/administration, Antiviral Agents/therapeutic use [MeSH], Original Research Article, Respiratory Tract Infections/virology [MeSH], Respiratory Tract Infections/drug therapy [MeSH], Respiratory Syncytial Virus Infections/drug therapy [MeSH], Child, Preschool [MeSH], Treatment Outcome, Double-Blind Method, Child, Preschool, Humans, Female, Respiratory Tract Infections

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38649595
https://repository.publisso.de/resource/frl:6518302
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39743
https://opus.bibliothek.uni-wuerzburg.de/files/39743/40272_2024_Article_625.pdf
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-397438
https://doi.org/10.1007/s40272-024-00625-x

Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era

Autoři: Götz, Veronika Mathé, Philipp Agarwal, Prerana a další

Zdroj: Infection

Témata: Male, Adult, Aged, 80 and over, SARS-CoV-2, Research, COVID-19, Middle Aged, Viral Load, Virus Replication, Antiviral Agents, COVID-19 Drug Treatment, 3. Good health, Immunocompromised Host, Phenotype, Treatment Outcome, Humans, Female, COVID-19/immunology [MeSH], Aged, 80 and over [MeSH], Viral Load/drug effects [MeSH], Aged [MeSH], Virus Replication [MeSH], COVID-19 Drug Treatment [MeSH], Antiviral therapy, Male [MeSH], Fibrotic-like lung changes, COVID-19/physiopathology [MeSH], Phenotype [MeSH], SARS-CoV-2 [MeSH], COVID-19/diagnosis [MeSH], Female [MeSH], COVID-19/virology [MeSH], Adult [MeSH], Humans [MeSH], Immunocompromised Host [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Omicron, Middle Aged [MeSH], Immunosuppression, Lower respiratory tract, Antiviral Agents/therapeutic use [MeSH], Retrospective Studies, Aged

Popis souboru: pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38095753
https://repository.publisso.de/resource/frl:6493504

No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals.

Autoři: Fombellida-Lopez, Céline Aguilar Ortmans, Diego Moutschen, Michel a další

Zdroj: Frontiers in Immunology, 16, 1628086 (2025)

Témata: HIV reservoir, antiretroviral therapy, correlation, immune activation, inflammation, dolutegravir, Pyridones, Heterocyclic Compounds, 3-Ring, Oxazines, Piperazines, Biomarkers, HIV Integrase Inhibitors, Humans, Pyridones/therapeutic use, Oxazines/therapeutic use, Piperazines/therapeutic use, Male, Middle Aged, Female, Adult, Viral Load/drug effects, CD4 Lymphocyte Count, HIV Integrase Inhibitors/therapeutic use, Leukocytes, Mononuclear/virology, Mononuclear/immunology, 3-Ring/therapeutic use, HIV Infections/drug therapy, HIV Infections/immunology

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2025.1628086/full; urn:issn:1664-3224; https://orbi.uliege.be/handle/2268/337098; info:hdl:2268/337098; info:pmid:40791593

Dostupnost: https://orbi.uliege.be/handle/2268/337098
https://orbi.uliege.be/bitstream/2268/337098/1/fimmu-16-1628086.pdf
https://doi.org/10.3389/fimmu.2025.1628086

Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients

Autoři: Ulrik Fahnøe Lone Wulff Madsen Peer Brehm Christensen a další

Zdroj: Microbiol Spectr
Microbiology Spectrum, Vol 12, Iss 9 (2024)
Fahnøe, U, Madsen, L W, Christensen, P B, Sølund, C S, Mollerup, S, Pinholt, M, Weis, N, Øvrehus, A & Bukh, J 2024, ' Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients ', Microbiology Spectrum, vol. 12, no. 9, e0064124 . https://doi.org/10.1128/spectrum.00641-24

Témata: Cyclopropanes, hepatitis C virus, Male, 0301 basic medicine, Aminoisobutyric Acids, Pyrrolidines, Hepacivirus, Viral/blood, Coinfection/drug therapy, HPgV-1, Viral, Phylogeny, Antiviral Agents/therapeutic use, Sulfonamides, 0303 health sciences, Genome, Coinfection, human pegivirus, Flaviviridae Infections, Middle Aged, Hepatitis C, Pegivirus/drug effects, QR1-502, 3. Good health, Drug Combinations, HCV, RNA, Viral, Female, Research Article, Benzimidazoles/therapeutic use, Adult, Genotype, Hepacivirus/genetics, Genome, Viral, Chronic/drug therapy, sofosbuvir, Microbiology, Antiviral Agents, 03 medical and health sciences, Quinoxalines, Pegivirus, Quinoxalines/therapeutic use, Humans, pegylated interferon, Flaviviridae Infections/drug therapy, direct-acting antivirals, DAA, Aged, metagenomics, Sulfonamides/therapeutic use, Hepatitis C, Chronic, Viral Load/drug effects, coinfection, RNA, Benzimidazoles, Metagenomics, Sofosbuvir/therapeutic use, Sofosbuvir

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39051781
https://doaj.org/article/65854ff025304af39a7f4d8aa882c8d7
https://curis.ku.dk/ws/files/405024044/Fulltext.pdf
https://portal.findresearcher.sdu.dk/da/publications/cd5966f9-a74d-4356-93ea-12d342b80009
https://doi.org/10.1128/spectrum.00641-24

Early Combination Therapy of COVID-19 in High-Risk Patients

Autoři: Hans Martin Orth Charlotte Flasshove Moritz Berger a další

Zdroj: Infection
Infection 52(3), 877-889 (2023). doi:10.1007/s15010-023-02125-5

Témata: Male, Adult, Ritonavir, Alanine, COVID-19, Viral Load/drug effects [MeSH], Aged [MeSH], Antibodies, Monoclonal/therapeutic use [MeSH], Immunocompromised host, SARS-CoV-2/drug effects [MeSH], Ritonavir/therapeutic use [MeSH], Individualized therapeutic approaches, COVID-19 Drug Treatment [MeSH], Male [MeSH], Virus Shedding/drug effects [MeSH], Drug Therapy, Combination [MeSH], Alanine/analogs, Prolonged viral shedding, Female [MeSH], Cytidine/analogs, COVID-19/virology [MeSH], Adult [MeSH], Alanine/therapeutic use [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Hydroxylamines [MeSH], Adenosine Monophosphate/analogs, Adenosine Monophosphate/therapeutic use [MeSH], Dual anti-SARS-CoV-2 therapies, Research, Antiviral Agents/therapeutic use [MeSH], SARS-CoV-2, Antibodies, Monoclonal, Cytidine, Middle Aged, Viral Load, Hydroxylamines, Antiviral Agents, Adenosine Monophosphate, 3. Good health, COVID-19 Drug Treatment, Virus Shedding, Humans, Female, Drug Therapy, Combination, Retrospective Studies, Aged

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38017344
https://repository.publisso.de/resource/frl:6523420
https://publications.rwth-aachen.de/record/982603

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials: week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Autoři: Cahn P. Madero J. S. Arribas J. R. a další

Přispěvatelé: Cahn P. Madero J. S. Arribas J. R. a další

Zdroj: The Lancet. 393:143-155

Témata: Male, Lamivudine / therapeutic use, HIV Dolutegravir, Heterocyclic Compounds, 3-Ring / therapeutic use, Tenofovir / therapeutic use, HIV Infections, Viral Load / drug effects, Piperazines, 0302 clinical medicine, Emtricitabine / therapeutic use, Emtricitabine, Tenofovir/adverse effects, Lamivudine/adverse effects, Adult, Anti-HIV Agents, Anti-Retroviral Agents, Double-Blind Method, Drug Therapy, Combination, Female, HIV-1, Heterocyclic Compounds, 3-Ring, Humans, Lamivudine, Middle Aged, RNA, Viral, Tenofovir, Viral Load, Medicine (all), HIV Infections / virology, Heterocyclic Compounds, 3-Ring/adverse effects, 16. Peace & justice, Emtricitabine/adverse effects, Anti-Retroviral Agents / adverse effects, Anti-Retroviral Agents / therapeutic use, HIV-1 / isolation & purification, 3. Good health, [SDV] Life Sciences [q-bio], Anti-HIV Agents / adverse effects, Anti-HIV Agents / therapeutic use, Heterocyclic Compounds, 3-Ring / adverse effects, Tenofovir / adverse effects, Pyridones, HIV Infections/drug therapy, Lamivudine / adverse effects, Anti-Retroviral Agents/adverse effects, 03 medical and health sciences, Emtricitabine / adverse effects, SDG 3 - Good Health and Well-being, Oxazines, HIV-1/isolation & purification, RNA, Viral/blood, Viral Load/drug effects, HIV Infections / drug therapy, Anti-HIV Agents/adverse effects, RNA, Viral / blood

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/30420123
https://air.unimi.it/handle/2434/629086
https://www.sciencedirect.com/science/article/abs/pii/S0140673618324620#!
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32462-0/fulltext
https://research.monash.edu/en/publications/dolutegravir-plus-lamivudine-versus-dolutegravir-plus-tenofovir-d
https://iris.unimore.it/handle/11380/1221490
https://www.sciencedirect.com/science/article/abs/pii/S0140673618324620
https://biblio.vub.ac.be/vubir/(1ae261bf-adab-4c02-9192-55337e187a2e).html

Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial

Autoři: Kosh Agarwal Sandy Liaw Edward Gane a další

Přispěvatelé: Kosh Agarwal Sandy Liaw Edward Gane a další

Zdroj: The Lancet Gastroenterology & Hepatology. 5:152-166

Témata: Oral, Adult, Male, 0301 basic medicine, Hepatitis B virus, Hepatitis B virus / drug effects, Adolescent, Administration, Oral, Viral Load / drug effects, Antiviral Agents, Dose-Response Relationship, Young Adult, 03 medical and health sciences, Chronic / drug therapy, Hepatitis B, Chronic, Double-Blind Method, Humans, Hepatitis B e Antigens, Aged, Retrospective Studies, 0303 health sciences, Dose-Response Relationship, Drug, Viral Core Proteins, Chronic / virology, Antiviral Agents / administration & dosage, Middle Aged, Viral Load, Hepatitis B e Antigens / immunology, Hepatitis B, 16. Peace & justice, 3. Good health, Treatment Outcome, Administration, Antiviral Agents / pharmacokinetics, Viral Core Proteins / antagonists & inhibitors, Chronic / metabolism, Female, Drug, Hepatitis B virus / immunology, Follow-Up Studies

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/31711752
https://findanexpert.unimelb.edu.au/scholarlywork/1429927-safety--pharmacokinetics--and-antiviral-effects-of-abi-h0731--a-hepatitis-b-virus-core-inhibitor--a-randomised--placebo-controlled-phase-1-trial
https://www.ncbi.nlm.nih.gov/pubmed/31711752
https://research.monash.edu/en/publications/safety-pharmacokinetics-and-antiviral-effects-of-abi-h0731-a-hepa
https://www.sciencedirect.com/science/article/abs/pii/S2468125319303462
https://europepmc.org/article/MED/31711752
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(19)30346-2/fulltext

Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.

Autoři: Ballif, M. Ledergerber, B. Battegay, M. a další

Přispěvatelé: Ballif, M. Ledergerber, B. Battegay, M. a další

Témata: Adult, Anti-Retroviral Agents/pharmacology, Anti-Retroviral Agents/therapeutic use, Cohort Studies, Drug Therapy, Combination, Female, Follow-Up Studies, HIV Infections/drug therapy, HIV-1/drug effects, Humans, Male, Medication Adherence, Middle Aged, Patient Selection, RNA, Viral/genetics, Switzerland, Treatment Failure, Viral Load/drug effects

Popis souboru: application/pdf

Relation: PLoS ONE; https://iris.unil.ch/handle/iris/66729; serval:BIB_323B4197158B; 000272830300029

Dostupnost: https://iris.unil.ch/handle/iris/66729
https://doi.org/10.1371/journal.pone.0008275

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.

Autoři: Rohrbach, J. Robinson, N. Harcourt, G. a další

Přispěvatelé: Rohrbach, J. Robinson, N. Harcourt, G. a další

Témata: Adult, Anti-HIV Agents/therapeutic use, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Cohort Studies, Female, HIV Infections/complications, HIV Infections/drug therapy, Hepacivirus/drug effects, Hepacivirus/genetics, Hepatitis C Antigens/immunology, Hepatitis C, Chronic/complications, Chronic/drug therapy, Humans, Immunity, Cellular/drug effects, Interferon-gamma/biosynthesis, Longitudinal Studies, Male, RNA, Viral/blood, T-Lymphocytes/drug effects, T-Lymphocytes/immunology, Viral Core Proteins/immunology, Viral Load/drug effects

Relation: Gut; https://iris.unil.ch/handle/iris/64704; serval:BIB_1B5145FB1283; 000282187100020

Dostupnost: https://iris.unil.ch/handle/iris/64704
https://doi.org/10.1136/gut.2009.205971

Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.

Autoři: Ngo-Giang-Huong, N. Wittkop, L. Judd, A. a další

Přispěvatelé: Ngo-Giang-Huong, N. Wittkop, L. Judd, A. a další

Témata: Adolescent, Anti-HIV Agents/therapeutic use, CD4 Lymphocyte Count, Child, Preschool, Drug Resistance, Viral/drug effects, Viral/genetics, Drug Therapy, Combination, Female, HIV Infections/drug therapy, HIV Infections/mortality, HIV Infections/virology, HIV-1/drug effects, Humans, Infant, Kaplan-Meier Estimate, Male, Mutation, Reverse Transcriptase Inhibitors/therapeutic use, Viral Load/drug effects, Children, First-line combination antiretroviral therapy, HIV, Pre-treatment drug resistance mutations, Virological failure

Popis souboru: application/pdf

Relation: BMC Infectious Diseases; https://iris.unil.ch/handle/iris/59418; serval:BIB_2E1EBE8BEC65; 000387727900001

Dostupnost: https://iris.unil.ch/handle/iris/59418
https://doi.org/10.1186/s12879-016-1968-2

Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir.

Autoři: Gutmann, C. Cusini, A. Günthard, H.F. a další

Přispěvatelé: Gutmann, C. Cusini, A. Günthard, H.F. a další

Témata: Adult, CD4 Lymphocyte Count, Drug Administration Schedule, Drug Combinations, Female, HIV Infections/drug therapy, HIV Infections/immunology, HIV Protease Inhibitors/administration & dosage, HIV Protease Inhibitors/adverse effects, HIV-1/drug effects, Humans, Lopinavir, Male, Middle Aged, Pyrimidinones/administration & dosage, Pyrimidinones/adverse effects, RNA, Viral/blood, Viral/cerebrospinal fluid, Ritonavir/administration & dosage, Ritonavir/adverse effects, Semen/virology, Time Factors, Treatment Failure, Viral Load/drug effects

Relation: AIDS; https://iris.unil.ch/handle/iris/259125; serval:BIB_DDB33C0BF17B; 000281646600007

Dostupnost: https://iris.unil.ch/handle/iris/259125
https://doi.org/10.1097/QAD.0b013e32833db9a1

Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.

Autoři: Staehelin, C. Keiser, O. Calmy, A. a další

Přispěvatelé: Staehelin, C. Keiser, O. Calmy, A. a další

Témata: Adult, Africa South of the Sahara/ethnology, African Continental Ancestry Group, Anti-HIV Agents/therapeutic use, CD4 Lymphocyte Count, Cohort Studies, European Continental Ancestry Group, Female, HIV Infections/drug therapy, HIV Infections/ethnology, Humans, Male, Middle Aged, Prospective Studies, Switzerland/epidemiology, Time Factors, Treatment Outcome, Viral Load/drug effects

Relation: Journal of Acquired Immune Deficiency Syndromes; https://iris.unil.ch/handle/iris/240225; serval:BIB_F25E54E38388; 000298292000016

Dostupnost: https://iris.unil.ch/handle/iris/240225
https://doi.org/10.1097/QAI.0b013e318236be70

Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.

Autoři: Chereau, F. Madec, Y. Sabin, C. a další

Přispěvatelé: Chereau, F. Madec, Y. Sabin, C. a další

Témata: Adult, Anti-HIV Agents/therapeutic use, Antiretroviral Therapy, Highly Active/methods, CD4 Lymphocyte Count/methods, CD4-Positive T-Lymphocytes/drug effects, CD4-Positive T-Lymphocytes/immunology, CD4-Positive T-Lymphocytes/virology, CD8-Positive T-Lymphocytes/drug effects, CD8-Positive T-Lymphocytes/immunology, Female, HIV Infections/drug therapy, HIV Infections/immunology, HIV Infections/virology, HIV-1/immunology, Humans, Male, Viral Load/drug effects, Viral Load/immunology, Viremia/drug therapy, Viremia/immunology, Viremia/virology, Virus Replication/immunology

Popis souboru: application/pdf

Relation: PLoS ONE; https://iris.unil.ch/handle/iris/210914; serval:BIB_C649BF89E594; 000399353500028

Dostupnost: https://iris.unil.ch/handle/iris/210914
https://doi.org/10.1371/journal.pone.0173893

Random forest machine learning algorithm predicts virologic outcomes among HIV infected adults in Lausanne, Switzerland using electronically monitored combined antiretroviral treatment adherence.

Autoři: Kamal, S. Urata, J. Cavassini, M. a další

Témata: Adult, Algorithms, Anti-HIV Agents/therapeutic use, Antiretroviral Therapy, Highly Active/methods, CD4 Lymphocyte Count, Cohort Studies, Female, HIV Infections/drug therapy, HIV Infections/epidemiology, HIV Infections/psychology, Humans, Machine Learning, Male, Medication Adherence/psychology, Medication Adherence/statistics & numerical data, Retrospective Studies, Switzerland/epidemiology, Treatment Outcome, Viral Load/drug effects, AIV/AIDS, Antiretroviral adherence, medication adherence, methods

Relation: AIDS Care; https://iris.unil.ch/handle/iris/204524; serval:BIB_C57093B4CF9D; 000526299700001

Dostupnost: https://iris.unil.ch/handle/iris/204524
https://doi.org/10.1080/09540121.2020.1751045

Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study.

Autoři: Boillat-Blanco, N. Darling, K.E. Schoni-Affolter, F. a další

Přispěvatelé: Boillat-Blanco, N. Darling, K.E. Schoni-Affolter, F. a další

Témata: Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Disease Management, Female, HIV Infections/drug therapy, HIV Infections/immunology, HIV Protease Inhibitors/therapeutic use, HIV-1/drug effects, HIV-1/physiology, Humans, Male, Middle Aged, Retrospective Studies, Reverse Transcriptase Inhibitors/therapeutic use, Switzerland, Treatment Outcome, Viral Load/drug effects, Viremia/drug therapy, Viremia/immunology, Virus Replication/drug effects

Relation: Antiviral Therapy; https://iris.unil.ch/handle/iris/156321; serval:BIB_EBE639128EA3; 000359909200007

Dostupnost: https://iris.unil.ch/handle/iris/156321
https://doi.org/10.3851/IMP2815

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.

Autoři: Bihl, F. Martinetti, G. Wandeler, G. a další

Přispěvatelé: Bihl, F. Martinetti, G. Wandeler, G. a další

Témata: Adult, Aged, Antiviral Agents/therapeutic use, Coinfection/drug therapy, Coinfection/virology, Drug Resistance, Viral/genetics, Female, Genotype, HIV Infections/complications, HIV Infections/drug therapy, Hepatitis B/complications, Hepatitis B/drug therapy, Hepatitis B virus/genetics, Humans, Lamivudine/therapeutic use, Male, Middle Aged, Retrospective Studies, Switzerland, Tenofovir/therapeutic use, Viral Load/drug effects, Young Adult

Popis souboru: application/pdf

Relation: BMC Gastroenterology; https://iris.unil.ch/handle/iris/134919; serval:BIB_9BB88EAC412E; 000357444700003

Dostupnost: https://iris.unil.ch/handle/iris/134919
https://doi.org/10.1186/s12876-015-0308-0